Guardant, Quest Diagnostics Partner to Expand Shield Test Access in US
September 24, 2025
Collaboration to enable streamlined and accelerated access to Shield blood-based colorectal cancer screening test across Quest’s vast network Guardant Health, Inc., a leading precision oncology